Van Meerten Stock Picks
Thu, Sep 19th, 2024
Follow Jim Van Meerten's Portfolios. View Their Performance Here.
Summary GeneDx Holdings Corp. offers AI-driven genomics-related diagnostic services, focusing on pediatrics, rare diseases, and hereditary cancer screening, with significant recent price appreciation. Barchart's technical indicators show 100% buy signals, a 919.55% gain in the last year, and strong momentum above key moving averages. Fundamental factors include a $970 million...
Read More